SCHEMBL26259901

SCHEMBL26259901

COc1cc2cc(OC)c(-c3ccco3)cc2cc1-c1ccco1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 3/20 0.49
▸ RAB9A P51151 3/20 0.49
▸ TP53 P04637 2/20 0.49
▸ NPC1 O15118 2/20 0.49
▸ PIK3R1 P27986 1/20 0.47
▸ PIK3CA P42336 1/20 0.47
▸ MEN1 O00255 4/20 0.47
▸ KMT2A Q03164 4/20 0.47
▸ MAPK1 P28482 2/20 0.47
▸ NFKB1 P19838 1/20 0.47
▸ NFKB2 Q00653 1/20 0.47
▸ RELA Q04206 1/20 0.47
▸ IMPDH2 P12268 1/20 0.46
▸ IMPDH1 P20839 1/20 0.46
▸ MAPT P10636 4/20 0.46
▸ TSHR P16473 1/20 0.46
▸ KDM4E B2RXH2 4/20 0.44
▸ ALDH1A1 P00352 4/20 0.44
▸ HPGD P15428 4/20 0.44
▸ TDP1 Q9NUW8 3/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27771980 0.87 KDM4E (0.52) SMN1; SMN2RAB9ATP53NPC1PIK3R1
SCHEMBL14003488 0.80 ACHE (0.48) SMN1; SMN2RAB9ATP53NPC1PIK3R1
SCHEMBL3685709 0.79 CYP3A4 (0.54) SMN1; SMN2RAB9ATP53NPC1MEN1
SCHEMBL7305407 0.77 ADORA2A (0.49) SMN1; SMN2RAB9ATP53NPC1PIK3R1
SCHEMBL10915716 0.77 IMPDH2 (0.59) SMN1; SMN2RAB9ATP53NPC1PIK3R1
SCHEMBL9670054 0.77 NPC1 (0.64) SMN1; SMN2RAB9ATP53NPC1PIK3R1
SCHEMBL30018913 0.74 SMN1; SMN2 (0.55) SMN1; SMN2RAB9ATP53NPC1PIK3R1
SCHEMBL27850505 0.73 MAPT (0.44) SMN1; SMN2RAB9ATP53NPC1MEN1
Hydrochloric Acid SCHEMBL31682446 0.73 TAAR1 (0.49) SMN1; SMN2RAB9ATP53NPC1PIK3R1
SCHEMBL26259455 0.73 PLAU (0.49) SMN1; SMN2RAB9ATP53NPC1PIK3R1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230287262-A1 PHOTON UPCONVERSION COMPOSITION, FILM, METHOD FOR CONVERTING VISIBLE LIGHT INTO ULTRAVIOLET LIGHT, AND COMPOUND KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION (JP) 2023-09-14 — — US disclosed
US-20230287262-A1 PHOTON UPCONVERSION COMPOSITION, FILM, METHOD FOR CONVERTING VISIBLE LIGHT INTO ULTRAVIOLET LIGHT, AND COMPOUND KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION (JP) 2023-09-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230287262-A1 PHOTON UPCONVERSION COMPOSITION, FILM, METHOD FOR CONVERTING VISIBLE LIGHT INTO ULTRAVIOLET LIGHT, AND COMPOUND NUDC, CCNL2, SPIN3 SMN1; SMN2 1455/4885RAB9A 2644/4885TP53 3338/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback